Evidence map›Paper›PMID 39961824›Full record

ArticleAnnals of hematology2025

Identification of a novel truncated pathogenic variant in PUS1 gene in two siblings of consanguineous Tunisian family: intrafamilial phenotypic variability related to mtDNA copy number.

Marwa Ammar, Sana Kmiha, Marwa Maalej, Rahma Felhi, Marwa Kharrat, Olfa Alila-Fersi, Jihen Chouchen, Ines Maaloul, Emna Mkaouar-Rebai, Thouraya Kammoun and 2 more

Abstract readCase Reports
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The impact of psuedouridine modification on human tRNA.Biochemical Society transactions · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marwa AmmarLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia. ammarmarwa27@gmail.com.
Sana KmihaDepartment of Pediatrics, CHU Hedi Chaker, Sfax, Tunisia.
Marwa MaalejLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia.
Rahma FelhiLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia.
Marwa KharratLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia.
Olfa Alila-FersiLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia.
Jihen ChouchenDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Ines MaaloulDepartment of Pediatrics, CHU Hedi Chaker, Sfax, Tunisia.
Emna Mkaouar-RebaiLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia.
Thouraya KammounDepartment of Pediatrics, CHU Hedi Chaker, Sfax, Tunisia.
Abdelaziz TliliDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Faiza FakhfakhLaboratory of Molecular and Functional Genetics, Faculty of Sciences of Sfax, University of Sfax, Route Soukra. Km 3., Sfax, Tunisia. faiza.fakhfakh02@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital sideroblastic anemia (CSA) is a rare genetic disorder caused by defects on heme biosynthesis and mitochondrial energy production. This disease is characterized by the presence of ring sideroblasts in the bone marrow caused by excessive iron accumulation in mitochondria of erythroblasts and by anemia of varying severity. In addition to its clinical variability, CSA is also characterized by genetic heterogeneity which required next-generation sequencing technologies to identify responsible gene. In the present study, whole-exome sequencing followed by Sanger sequencing were performed on a consanguineous family including two patients with congenital sideroblastic anemia. Mitochondrial DNA deletion and copy number were tested respectively by long PCR and QPCR. Subsequent bioinformatic investigations were performed using several programs. WES and Sanger sequencing results revealed a novel pathogenic variant c.579-580insT (p.N194X) in the PUS1 gene. Several bioinformatic tools supported that this variant was disease-causing. This variation leads to an incomplete catalytic site which will be probably non-functional and could disturb heme biosynthesis. In addition, no mtDNA deletion was detected in the two patients whereas mtDNA quantification revealed a decrease of mtDNA copy number in P2 and its increasing in P1. The increase in mtDNA copy number, which is most likely connected to a compensatory mechanism, may be the cause of the moderate phenotypic severity observed in P1 with the same p.N194X variant with P2. In conclusion, we identified a novel truncated pathogenic variant in PUS1 gene in two siblings of consanguineous family with intrafamilial phenotypic variability related to mtDNA copy number.

Indexed as

5-Aminolevulinate SynthetaseAnemia, SideroblasticDNA Copy Number VariationsDNA, MitochondrialConsanguinityHumansPedigreePhenotypeSiblingsTunisia5-Aminolevulinate SynthetaseDNA, MitochondrialMitochondrial diseasesMLASA1 syndromePathogenic variantTunisiaWhole exome sequencing

Identifiers

PMID39961824
PMCPMC11971136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.